Latest Regulatory Approvals News

Tamboran Resources has reported a record 30-day initial production flow rate from its Shenandoah South 2H sidetrack well in the Beetaloo Basin, aligning with prolific US shale benchmarks and setting the stage for commercial gas sales by mid-2026.

Lakes Blue Energy has obtained Victorian government approval to drill the Wombat-5 appraisal well, a key step toward unlocking significant gas resources amid looming East Coast supply shortages.

Australian Strategic Materials (ASM) has announced an underwritten share purchase plan to raise up to A$3 million, supporting its advancing Dubbo Project and ramp-up of the Korean Metals Plant. The company also outlines ambitions for a US metals facility amid strong government backing and strategic partnerships.

Vintage Energy has agreed to sell its entire 25% interest in the PEP 171 permit in Victoria’s Otway Basin to Beach Energy for $1.25 million, marking a strategic pivot towards its Southern Flank gas fields project.

Zenith Minerals has launched a fully underwritten $3.5 million entitlement offer to fund drilling at its key gold projects in Western Australia and Queensland, aiming to expand mineral resources and advance exploration.

PointsBet Holdings has formalised a conditional takeover bid deed with MIXI at $1.20 per share, activating if shareholders reject the current scheme of arrangement. The deal hinges on key regulatory approvals and a minimum 50.1% acceptance threshold.

Artrya Limited has submitted a pivotal FDA 510(k) application for its AI-powered Salix® Coronary Plaque module, aiming for clearance in Q3 2025 and a lucrative US commercial launch.

Santos Limited has received a compelling non-binding proposal from the XRG Consortium to acquire the company at a significant premium, prompting the board to engage in due diligence and negotiations. This move could reshape the Australian energy landscape if finalized.

EVE Health Group’s subsidiary Nextract has inked a pivotal two-year agreement with TeleDocs Clinic, enabling nationwide online prescribing of its upcoming erectile dysfunction and dysmenorrhea products ahead of regulatory approval.

EMVision Medical Devices has secured a $5 million non-dilutive government grant to accelerate global commercialisation of its innovative First Responder portable brain scanner, aimed at revolutionising pre-hospital stroke and brain injury care.

Talga Group’s Nunasvaara South graphite mine zoning plan process shifts to regional government after local deadline missed, advancing a key step in Sweden’s battery materials push.

Bubs Australia has submitted critical clinical trial data to the US FDA, marking a pivotal step toward permanent approval for its infant formulas in the US market.